Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Grants

Publications

Bailey, Donald E., Cristina C. Hendrix, Karen E. Steinhauser, Karen M. Stechuchak, Laura S. Porter, Julie Hudson, Maren K. Olsen, et al. “Randomized trial of an uncertainty self-management telephone intervention for patients awaiting liver transplant.” Patient Educ Couns 100, no. 3 (March 2017): 509–17. https://doi.org/10.1016/j.pec.2016.10.017.

PMID
28277289
Full Text

O’Leary, Jacqueline G., Robert J. Fontana, Kimberly Brown, James R. Burton, Roberto Firpi-Morell, Andrew Muir, Christopher O’Brien, et al. “Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.” Transpl Int 30, no. 2 (February 2017): 196–208. https://doi.org/10.1111/tri.12896.

PMID
27896858
Full Text

Patel, Yuval A., and Andrew J. Muir. “Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting Antivirals.” Curr Hepatol Rep 15, no. 4 (December 2016): 285–90. https://doi.org/10.1007/s11901-016-0319-5.

PMID
28584732
Full Text

Patel, Yuval A., Jacqueline B. Henson, Julius M. Wilder, Jiayin Zheng, Shein-Chung Chow, Carl L. Berg, and Andrew J. Muir. “The Impact of HLA Serotyping and HLA Matching for PSC, PSC/AIH, AIH, PBC/AIH, and PBC Patients on Post-Liver Transplant Graft Failure: an Analysis of the UNOS Database.” In Hepatology, 64:500A-500A. WILEY, 2016.

Scholars@Duke

Sena, Arlene C., Alison Hilton, Christopher B. Hurt, Heidi Swygard, Claire Farel, David Wohl, and Andrew J. Muir. “Bridging the gap: Facilitating linkage to care for persons identified with chronic hepatitis C infections through a public health program.” In Hepatology, 64:867A-867A. WILEY, 2016.

Scholars@Duke

Muir, Andrew J., Maria Buti, Ronald Nahass, Kosh Agarwal, Edward J. Gane, Simone I. Strasser, Alessandra Mangia, et al. “Long-Term Follow-up of Patients with Chronic HCV Infection and Compensated or Decompensated Cirrhosis Following Treatment with Sofosbuvir-Based Regimens.” In Hepatology, 64:437A-438A. WILEY, 2016.

Scholars@Duke

Nitsche, Bruce, Sara Miller, and Andrew J. Muir. “Improving HCV Testing in Alignment with Current Guidelines: Technology Alone is Not the Answer.” In Hepatology, 64:856A-857A. WILEY, 2016.

Scholars@Duke

Henson, Jacqueline B., Julius M. Wilder, Yuval A. Patel, Jiayin Zheng, Shein-Chung Chow, Lindsay Y. King, and Andrew J. Muir. “Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group.” In Hepatology, 64:185A-185A. WILEY, 2016.

Scholars@Duke

Pages